FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used as a method for prediction of risk of progressing exertional angina, developing left ventricular hypertrophy and obesity in patients with ischemic heart disease combined with diabetes type 2. Method: detecting genetic polymorphism T1565S of ITGB3 gene in the patients with ischemic heart disease, occurring on the background of type 2 diabetes mellitus. If observing in patients with allele c gene ITGB3 shows a high risk of progression of exertional angina, developing left ventricular hypertrophy and obesity.
EFFECT: using the invention in medicine allows predicting with high probability of developing complications in ischemic heart disease associated with type 2 diabetes mellitus.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS WITHIN ONE YEAR AFTER A MYOCARDIAL INFARCTION BASED ON MOLECULAR GENETIC ANALYSIS | 2021 |
|
RU2767269C1 |
| METHOD OF PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2670689C9 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF ATRIAL FIBRILLATION IN WOMEN WITH CORONARY HEART DISEASE | 2017 |
|
RU2657942C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
| METHOD FOR DETERMINING THE RISK OF MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION USING GENETIC MARKERS | 2019 |
|
RU2711623C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS COMBINED WITH SUBCLINICAL THYROTOXICOSIS | 2018 |
|
RU2691620C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR ANEURYSM IN PATIENTS AFTER MYOCARDIAL INFARCTION, TAKING INTO ACCOUNT GENETIC FACTORS | 2022 |
|
RU2801684C1 |
| METHOD FOR PREDICTING THE RISK OF THROMBOTIC COMPLICATIONS OF PATIENTS WITH CARDIOVASCULAR PATHOLOGY | 2020 |
|
RU2746234C1 |
| METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
| METHOD FOR THERAPY OF ARTERIAL PRESSURE IN OBESE CHILDREN BASED ON THE STUDY OF PATHOLOGICAL GENE ALLELES | 2022 |
|
RU2787390C1 |
